Financhill
Back

Meta Platforms Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
66

META
Meta Platforms

Last Price:
461.32
Seasonality Move:
3.9%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
45.13
Seasonality Move:
-13.89%
Buy
66
Meta Platforms (META) is a Buy

Is Meta Platforms a Buy, Sell or Hold?

  • The current Meta Platforms [META] share price is $488.69. The Score for META is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • META is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $45.18. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

META Stock Price Chart

What is Meta Platforms's stock price today?

  • The Meta Platforms share price today is $488.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and META is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $45.18
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.

META Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.37 Sell
Relative Strength Index (14 RSI): 46.21 Sell
Chaikin Money Flow: -6745322 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.9 Buy
Relative Strength Index (14 RSI): 61.13 Buy
Chaikin Money Flow: 71994 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

META Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 484.44 Buy
20-day SMA: 504.69 Sell
50-day SMA: 492.69 Sell
200-day SMA: 427.42 Buy
8-day EMA: 488.55 Buy
20-day EMA: 496.48 Sell
50-day EMA: 493.75 Sell
200-day EMA: 433.06 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.22 Buy
20-day SMA: 42.49 Buy
50-day SMA: 41.38 Buy
200-day SMA: 42.96 Buy
8-day EMA: 43.89 Buy
20-day EMA: 42.88 Buy
50-day EMA: 42.42 Buy
200-day EMA: 43.26 Buy

Meta Platforms Earnings Growth & META Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.29 per share, an increase next quarter of $0.67 per share, an increase this year of $5.89 per share, and an increase next year of $2.94 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Meta Platforms Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):